Role of in-hospital initiation of carvedilol to improve treatment rates and clinical outcomesFONAROW, Gregg C.The American journal of cardiology. 2004, Vol 93, Num 9A, pp 77B-81B, issn 0002-9149, SUPArticle

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial) : a randomised, double-blind, placebo-controlled trial. CommentaryFONAROW, Gregg C.Lancet (British edition). 2008, Vol 372, Num 9645, issn 0140-6736, 1195-1196, 1223-1230 [10 p.]Article

Epidemiology and risk stratification in acute heart failureFONAROW, Gregg C.The American heart journal. 2008, Vol 155, Num 2, pp 200-206, issn 0002-8703, 7 p.Article

Hospital protocols and evidence-based therapies : The importance of integrating aldosterone blockade into the management of patients with Post-acute Myocardial Infarction Heart FailureFONAROW, Gregg C.Clinical cardiology (Mahwah, NJ). 2006, Vol 29, Num 1, pp 4-8, issn 0160-9289, 5 p.Article

Practical considerations of β-blockade in the management of the post-myocardial infarction patientFONAROW, Gregg C.The American heart journal. 2005, Vol 149, Num 6, pp 984-993, issn 0002-8703, 10 p.Article

In-hospital initiation of statin therapy in acute coronary syndromes : Maximizing the early and long-term benefitsFONAROW, Gregg C.Chest. 2005, Vol 128, Num 5, pp 3641-3651, issn 0012-3692, 11 p.Article

Assessment and treatment of acute heart failure: Case study: Dry and warm profileFONAROW, Gregg C.Clinical cardiology. Supplement (Mahwah, NJ). 2004, Vol 27, Num 9, pp V.14-V.15Article

Approach to the management of diabetic patients with heart failure: Role of thiazolidinedionesFONAROW, Gregg C.The American heart journal. 2004, Vol 148, Num 4, pp 551-558, issn 0002-8703, 8 p.Article

Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosisFONAROW, Gregg C.Vascular medicine (London). 2002, Vol 7, Num 3, pp 187-194, issn 1358-863X, 8 p.Article

Carvedilol: Its Role in Cardiovascular MedicineGHEORGHIADE, Mihai; FONAROW, Gregg C.The American journal of cardiology. 2004, Vol 93, Num 9A, issn 0002-9149, 84 p., SUPSerial Issue

Management of post-myocardial infarction patients with left ventricular systolic dysfunctionGHEORGHIADE, Mihai; FONAROW, Gregg C.The American journal of medicine. 2007, Vol 120, Num 2, pp 115-126, issn 0002-9343, 12 p.Article

Home Monitoring for Heart Failure ManagementBUI, Anh L; FONAROW, Gregg C.Journal of the American College of Cardiology. 2012, Vol 59, Num 2, pp 97-104, issn 0735-1097, 8 p.Article

Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohortsHEIDENREICH, Paul A; FONAROW, Gregg C.The American heart journal. 2006, Vol 152, Num 5, pp 935-939, issn 0002-8703, 5 p.Article

Relation of loop diuretic dose to mortality in advanced heart failureESHAGHIAN, Shervin; HORWICH, Tamara B; FONAROW, Gregg C et al.The American journal of cardiology. 2006, Vol 97, Num 12, pp 1759-1764, issn 0002-9149, 6 p.Article

Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failureSMOOKE, Stephanie; HORWICH, Tamara B; FONAROW, Gregg C et al.The American heart journal. 2005, Vol 149, Num 1, pp 168-174, issn 0002-8703, 7 p.Article

Glucose, Obesity, Metabolic Syndrome, and Diabetes: Relevance to Incidence of Heart Failure : Heart failureHORWICH, Tamara B; FONAROW, Gregg C.Journal of the American College of Cardiology. 2010, Vol 55, Num 4, pp 283-293, issn 0735-1097, 11 p.Article

Total cholesterol levels and mortality risk in nonischemic systolic heart failureAFSARMANESH, Nasim; HORWICH, Tamara B; FONAROW, Gregg C et al.The American heart journal. 2006, Vol 152, Num 6, pp 1077-1083, issn 0002-8703, 7 p.Article

Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: Carvedilol in severe heart failureFOWLER, Michael B.The American journal of cardiology. 2004, Vol 93, Num 9A, pp 35B-39B, issn 0002-9149, SUPArticle

Special considerations for carvedilol use in heart failureYANCY, Clyde W.The American journal of cardiology. 2004, Vol 93, Num 9A, pp 64B-68B, issn 0002-9149, SUPArticle

B-type natriuretic peptide: Spectrum of application. Nesiritide (recombinant BNP) for heart failureFONAROW, Gregg C.Heart failure reviews. 2003, Vol 8, Num 4, pp 321-325, issn 1382-4147, 5 p.Article

Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failureRALLI, Sonia; HORWICH, Tamara B; FONAROW, Gregg C et al.The American heart journal. 2005, Vol 150, Num 6, pp 1220-1227, issn 0002-8703, 8 p.Article

An approach to heart failure and diabetes mellitusFONAROW, Gregg C.The American journal of cardiology. 2005, Vol 96, Num 4, pp 47E-52E, issn 0002-9149, SUPConference Paper

Tolerability of carvedilol in heart failure: Clinical trials experienceKRUM, Henry.The American journal of cardiology. 2004, Vol 93, Num 9A, pp 58B-63B, issn 0002-9149, SUPArticle

Comparison of Usefulness of Each of Five Predictors of Mortality and Urgent Transplantation in Patients With Advanced Heart FailureSACHDEVA, Amit; HORWICH, Tamara B; FONAROW, Gregg C et al.The American journal of cardiology. 2010, Vol 106, Num 6, pp 830-835, issn 0002-9149, 6 p.Article

Cardiac remodeling in coronary artery diseaseSHARPE, Norman.The American journal of cardiology. 2004, Vol 93, Num 9A, pp 17B-20B, issn 0002-9149, SUPArticle